Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Advanced Drug Delivery Reviews
|
August 18, 2009
Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics
Rogério Gaspar, Ruth Duncan
Journal of Drug Targeting
|
August 3, 2007
Hiroshi Maeda--defining the pathway to targeted cancer therapy
Ruth Duncan, Len Seymour
Molecular Pharmaceutics
|
October 7, 2011
Nanomedicine(s) under the microscope
Ruth Duncan, Rogerio Gaspar
Biomacromolecules
|
April 10, 2009
Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate
Elaine L Ferguson, Ruth Duncan
Advanced Drug Delivery Reviews
|
September 18, 2012
Polymer therapeutics-prospects for 21st century: the end of the beginning
Ruth Duncan, María J Vicent
Trends in Biotechnology
|
November 26, 2005
Polymer conjugates: nanosized medicines for treating cancer
María J Vicent, Ruth Duncan
Advanced Drug Delivery Reviews
|
December 17, 2009
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
Ruth Duncan, María J Vicent
Molecular Pharmaceutics
|
August 1, 2012
Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges
Ruth Duncan, Simon C W Richardson
Biomacromolecules
|
April 11, 2007
Using small-angle neutron scattering to study the solution conformation of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates
Alison Paul, Maria J Vicent, Ruth Duncan
Advanced Drug Delivery Reviews
|
November 5, 2003
Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems
Arwyn T Jones, Mark Gumbleton, Ruth Duncan
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Advanced Drug Delivery Reviews
|
August 18, 2009
Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics
Rogério Gaspar, Ruth Duncan
Journal of Drug Targeting
|
August 3, 2007
Hiroshi Maeda--defining the pathway to targeted cancer therapy
Ruth Duncan, Len Seymour
Molecular Pharmaceutics
|
October 7, 2011
Nanomedicine(s) under the microscope
Ruth Duncan, Rogerio Gaspar
Biomacromolecules
|
April 10, 2009
Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate
Elaine L Ferguson, Ruth Duncan
Advanced Drug Delivery Reviews
|
September 18, 2012
Polymer therapeutics-prospects for 21st century: the end of the beginning
Ruth Duncan, María J Vicent
Trends in Biotechnology
|
November 26, 2005
Polymer conjugates: nanosized medicines for treating cancer
María J Vicent, Ruth Duncan
Advanced Drug Delivery Reviews
|
December 17, 2009
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
Ruth Duncan, María J Vicent
Molecular Pharmaceutics
|
August 1, 2012
Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges
Ruth Duncan, Simon C W Richardson
Biomacromolecules
|
April 11, 2007
Using small-angle neutron scattering to study the solution conformation of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates
Alison Paul, Maria J Vicent, Ruth Duncan
Advanced Drug Delivery Reviews
|
November 5, 2003
Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems
Arwyn T Jones, Mark Gumbleton, Ruth Duncan
Page
of 7